In particular, the levels of IL-18 and GRO-α appear to be changed in both serum and brain of bvFTD patients, making these two cytokines possible inflammation biomarkers for bvFTD. The gene discussed is CXCL1; the disease is behavioral variant of frontotemporal dementia.